These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 30968243)

  • 1. Clinical and histological features and therapeutic strategies for IgA nephropathy.
    Moriyama T
    Clin Exp Nephrol; 2019 Sep; 23(9):1089-1099. PubMed ID: 30968243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
    Komatsu H; Fujimoto S; Kikuchi M; Sato Y; Kitamura K
    Ren Fail; 2012; 34(4):448-53. PubMed ID: 22260382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematuria was a high risk for renal progression and ESRD in immunoglobulin a nephropathy: a systematic review and meta-analysis.
    He P; Wang H; Huang C; He L
    Ren Fail; 2021 Dec; 43(1):488-499. PubMed ID: 33685345
    [No Abstract]   [Full Text] [Related]  

  • 5. Tonsillectomy with steroid pulse: a curative therapy for IgA nephropathy.
    Hotta O
    Adv Otorhinolaryngol; 2011; 72():37-9. PubMed ID: 21865685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonsillectomy for IgA nephropathy: a meta-analysis.
    Liu LL; Wang LN; Jiang Y; Yao L; Dong LP; Li ZL; Li XL
    Am J Kidney Dis; 2015 Jan; 65(1):80-7. PubMed ID: 25446024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid pulse therapy transiently destroys the discriminative histological structure of tonsils in IgA nephropathy: Tonsillectomy should be performed before or just after steroid pulse therapy.
    Adachi M; Sato M; Miyazaki M; Hotta O; Hozawa K; Sato T; Taguma Y; Katori Y
    Auris Nasus Larynx; 2018 Dec; 45(6):1206-1213. PubMed ID: 29789195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
    Rauta V; Finne P; Fagerudd J; Rosenlöf K; Törnroth T; Grönhagen-Riska C
    Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
    J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers for the progression of IgA nephropathy.
    Maixnerova D; Reily C; Bian Q; Neprasova M; Novak J; Tesar V
    J Nephrol; 2016 Aug; 29(4):535-41. PubMed ID: 27142988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Nagata M; Tsuchimoto A; Hirakata H; Kitazono T; Tsuruya K
    Clin Exp Nephrol; 2016 Oct; 20(5):689-698. PubMed ID: 26564155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis and treatment of IgA nephropathy.
    Kawasaki Y
    Fukushima J Med Sci; 2008 Dec; 54(2):43-60. PubMed ID: 19418967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for a systematic review of the application of the kidney failure risk equation and Oxford classification in estimating prognosis in IgA nephropathy.
    Toal M; Fergie R; Quinn M; Hill C; O'Neill C; Maxwell AP
    Syst Rev; 2024 May; 13(1):122. PubMed ID: 38704598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.
    Thompson A; Carroll K; A Inker L; Floege J; Perkovic V; Boyer-Suavet S; W Major R; I Schimpf J; Barratt J; Cattran DC; S Gillespie B; Kausz A; W Mercer A; Reich HN; H Rovin B; West M; Nachman PH
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):469-481. PubMed ID: 30635299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical data.
    Tomino Y
    Kidney Blood Press Res; 2014; 39(5):450-89. PubMed ID: 25501571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
    Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in risk prediction, therapeutics and pathogenesis of IgA nephropathy.
    Moran SM; Cattran DC
    Minerva Med; 2019 Oct; 110(5):439-449. PubMed ID: 31142099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.
    Pesce F; Diciolla M; Binetti G; Naso D; Ostuni VC; Di Noia T; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Di Sciascio E; Schena FP
    Nephrol Dial Transplant; 2016 Jan; 31(1):80-6. PubMed ID: 26047632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.